EW250117C82500
- 0.04
- 0.000.00%
Edwards Lifesciences Newsroom
Edwards Lifesciences Analyst Ratings
Wolfe Research Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Announces Target Price $60
Edwards Lifesciences Downgraded to Underperform at Wolfe Research
Citi Maintains Edwards Lifesciences(EW.US) With Buy Rating
Bernstein Maintains Edwards Lifesciences(EW.US) With Hold Rating
Bernstein Upgrades Edwards Lifesciences(EW.US) to Hold Rating, Raises Target Price to $74
RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $85
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
Evercore Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $75
Deutsche Bank Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $85
Deutsche Bank Sticks to Its Buy Rating for Edwards Lifesciences (EW)
Baird Adjusts Edwards Lifesciences Price Target to $70 From $68, Maintains Neutral Rating
Morgan Stanley Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Cuts Target Price to $46
Edwards Lifesciences: Competitive Pressures and Valuation Concerns Lead to Sell Rating
Bernstein Downgrades Edwards Lifesciences(EW.US) to Sell Rating, Announces Target Price $73
BofA Securities Upgrades Edwards Lifesciences(EW.US) to Buy Rating, Raises Target Price to $90
BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Price Target Is $90
Edwards Lifesciences Analyst Ratings
Citi Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $83
Truist Financial Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $78